Placebo-controlled, double-blind, crossover clinical trial for the effect of single intake of soybean processed food rich in beta-conglycinin on postprandial hyperlipidemia
- Conditions
- dyslipidemia
- Registration Number
- JPRN-UMIN000012031
- Lead Sponsor
- Hokkaido Information University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1)Subjects who are under medication for chronic ailments. 2)Subjects with serious diseases and infections. 3)Subjects with clinical history of gastrointestinal surgery. 4)Subjects with frequent complaints of post-menopausal symptoms. 5)Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. 6)Subjects with serious anemia. 7)Subjects with a history of allergy to medicine and food, especially soybean. 8)Subjects routinely on supplementation which would affect the lipid metabolism. 9)Heavy smokers and alcohol addicts, or subjects with irregular lifestyle. 10)Subjects who donate 400ml whole blood within 12 weeks or who donate plasma or platelets within 4 weeks prior to supplementation. 11)Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study. 12)Subjects who participate in other clinical trials within the last one month prior to the current clinical trial. 13)Subjects who are not eligible due to physician's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method